Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Vera gone??..
View:
Post by stocksnbonds458 on Aug 31, 2022 5:30pm

Vera gone??..

I hope to god thats not true, if Vera left that is absolutely devastating. Her coming on board was a major coup for the company, if she is gone it does not bode well for the future.
Comment by fasttrack5 on Aug 31, 2022 5:43pm
Not devastateing at all. she was hired on a short ter m contract. which expired.
Comment by stocksnbonds458 on Aug 31, 2022 5:48pm
Sorry fastrack, can't put lipstick on that pig!!
Comment by Rumpl3StiltSkin on Aug 31, 2022 6:02pm
I was bummed when I first saw she was leaving S&B. Then I looked at the CR/PR data. TLT might not be able to afford to keep her on right now and it appears they will achieve BTD and AA without any problem as the optimized patient groups move through the trial. So maybe she has done her work?
Comment by james700 on Sep 01, 2022 2:02am
It is a pleasure to join the Theralase clinical research team, reporting to Dr. Mandel. I feel my extensive global experience in clinical research and quality assurance will support the Companys primary objective of successfully developing with the objective of commercializing its Anti-Cancer Therapy (ACT) technology.
Comment by fasttrack5 on Sep 01, 2022 2:11am
That was 2021 she just left according to the latest report
Comment by socksnblonds642 on Aug 31, 2022 6:39pm
That's so untrue. I've done it. 
Comment by Rumpl3StiltSkin on Aug 31, 2022 7:25pm
Ha Ha I always thought you 2 S&Bs were/are the same person....
Comment by Lesalpes29 on Aug 31, 2022 8:18pm
Those clowns are the same person... for the Vera departure my thought is easy to understand... her in or her out won't change anyting on results to come and the next steps to follow after! We will see.
Comment by Rumpl3StiltSkin on Aug 31, 2022 9:34pm
I agree with you on the Vera departure, not sure I agree about S&B(s) being clown(s) Though maybe clowning us a bit today...  :-)
Comment by StevenBirch on Aug 31, 2022 10:27pm
No disrespect to Vera but most people here built their positions in TLT long before they, me for sure, even knew who she was. She may have fulfilled her duties for all we know and the short blurb surely doesn't explain why she left but negative speculation is never in short supply around here. 
Comment by patience69 on Aug 31, 2022 10:36pm
Maybe I am crazy & totally off the wall but did anyone ever consider the fact that maybe she was not ever really hired by Theralase. What if she was there to verify & dig into everything on behalf of a potential partner or buyout candidate. It would not be unreasonable to take that length of time to decide! Just throwing it out there!
Comment by fasttrack5 on Aug 31, 2022 10:47pm
IDr. Madzarevic, appointed Director of Clinical Development and Quality Assurance at Theralase® stated, “It is a pleasure to join the Theralase® clinical research team, reporting to Dr. Mandel. I feel my extensive global experience in clinical research and quality assurance will support the Company’s primary objective of successfully developing with the objective of ...more  
Comment by Rumpl3StiltSkin on Aug 31, 2022 10:50pm
There as a consultant, to get everything perfect for the FDA.. Some have surmised.
Comment by Camphikefish on Aug 31, 2022 11:34pm
It seems to me had Vera completed all she had been tasked with she would have been publicly thanked and given high praise in the last report. Most of the time when a highly significant employee departs on great terms they are given a chance to provide a brief and positive departing comment. Or am I misreading this? You folks know better than me who are seasoned investors. Just came across in a ...more  
Comment by Rumpl3StiltSkin on Aug 31, 2022 11:45pm
Yeah just the one line mention.... I'm hoping it is just oversight that they didn't explain her departure better...
Comment by fasttrack5 on Sep 01, 2022 12:25am
Good point Camphikefish. I emailed the company - if I get a reply I will report. Fast
Comment by stocksnbonds458 on Sep 01, 2022 8:46am
That sounds like wishful thinking Camp, that she had completed he talk. In her own words she said her task was to bring the the product to market-period!! Why did Theralase mention her leaving the company in a one liner couched within a paragraph in the release Monday that many of missed? I may be making a big deal about her leaving, because it is a big deal
Comment by patience69 on Sep 01, 2022 9:06am
Skys I sent you a PM
Comment by skys1 on Sep 01, 2022 4:41am
patience69, that's great "outside the box" thinking. She was sent by Big Pharma to get the inside technical info on Theralase before her sponsering enity went at risk to put a multi $billion offer on the table. Interesting. After all, she did come from Big Pharma and stayed several months or about about the time needed to get a good in dept look at the inside technical info on the ...more  
Comment by Oilminerdeluxe on Sep 01, 2022 5:37am
The good part is, the stock can only lose 28 cents more...  Sorry, my twisted sense of humor. Dear lord, this is a strange company. But the date appears to be good enough. On to the next update. Let the wait begin.
Comment by Oilminerdeluxe on Sep 01, 2022 5:48am
"data" appears to be... My spelling is a reflection of my intelligence :-)
Comment by stocksnbonds458 on Sep 01, 2022 9:53am
I would like to know what all the smart guys have to say about Vera leaving. They have also not been too active with regards to opinions and analysis of the most recent results. By smart guys I am referring to Eoganacht, CancerSlayer, EnriqueSauve, ScienceFirst, Oden6570 amongst others. Their opinions are of great value
Comment by Rumpl3StiltSkin on Sep 01, 2022 10:24am
SF has been MIA since this news release, 'cept for one small comment.
Comment by enriquesuave on Sep 01, 2022 11:01am
I have no clue why Dr Vera has left, but the first idea, would be that she has completed her mission, which was to ensure the trial is well run and coordinated with all sites, as well as proper data collection and reporting IMO.  If she has met with all the parties involved and set up all necessary guidelines to follow, what more can she do?  The rest is follow the steps to BTD, AA and ...more  
Comment by Rumpl3StiltSkin on Sep 01, 2022 11:31am
I agree, It would be nice to know for sure. That is the only way we'll know. 
Comment by stocksnbonds458 on Sep 01, 2022 11:37am
With all due respect Enrique, in her own words she was there to bring this to commercialization. Per Vera: "I feel my extensive global experience in clinical research and quality assurance will support the Companys primary objective of successfully developing with the objective of commercializing its Anti-Cancer Therapy (ACT) technology". At the very least, IMHO, the shareholders deserve ...more  
Comment by Lesalpes29 on Sep 01, 2022 12:01pm
This is it, we are very near to commercialization and strategically TLT won’t comment further on Vera departure! Glass half full for me!
Comment by CancerSlayer on Sep 01, 2022 8:05pm
  In addition to cost savings, considering our new fully equipped research center (effective 4/2022) & recent association with LKSKI, I imagine there was also a fair degree of duplication/overlap in expertise with respect to clinical trial guidance & commercialization.  Nonetheless, I feel confident TLT benefited from whatever additional info/value she was able to provide (in ...more  
Comment by Rumpl3StiltSkin on Sep 01, 2022 8:43pm
Well, it can't just be me? Isn't this NR the first time in this Phase 2 where no one was confused by the CR data?? I think we've all been very correctly assesing what this group of numbers has been telling us... :-) Maybe Dr. Rad did do her work afterall...??
Comment by Legit62 on Sep 01, 2022 9:01pm
I believe next set of Data will be spelled out in FDA format, where everyone will understant it, BTD
Comment by Rumpl3StiltSkin on Sep 01, 2022 9:49pm
Ha Ha Ha, yes Legit, nice! I think so too.
Comment by CancerSlayer on Sep 01, 2022 10:07pm
  "no one was confused..." Well, almost right Rumpl...I have this tendency at times to not only confuse myself, but also others in the process.  Used to be good at this stuff but father time has kicked in.  My apologies to all.  Be best to just wait for that elusive BTD ; )...GLTA.
Comment by Yoly900 on Sep 02, 2022 4:28am
We will be bankrupt by years end no news release is making this pos company go up none Whst so ever never did never will just a pos dream company it's pathetic how we got scammed all those years yeah he's got the goods alright for sure.
Comment by Yoly900 on Sep 02, 2022 4:32am
Look they're worried about lawsuits to get more money from us pathetic they know they ain't getting Shite I could say whatever I fkn want about Roger his wife etc etc etc your gonna sue me stupidest thing I saw from a ceo Penney stock fraud he wants to sue us shareholders thst for sure tells you a whole lot. He's looking for more money from us he's a bad man must be punished ...more  
Comment by Lesalpes29 on Sep 02, 2022 6:06am
You are saying that you are a share holder of a bankrupcy stock? Honestly you look suspicious to say the least.
Comment by Rumpl3StiltSkin on Sep 02, 2022 11:22am
Ok, so Dr Vera got the CR data organized to the point where we can all understand them, before her departure, IMO. With one Exception, CancerSlayer! ;-)
Comment by Johnandrose22 on Sep 01, 2022 11:06am
I'll chime in here... For me, the sudden departure of Dr. Vera is, at the very least, unsettling. Her admission to the company in November, 2021 was met with such welcome and fanfare with statements by the CEO and the Board of Directors, as well as her own enthusiastic statements can only be juxtaposed by the sterile notice of her departure. I have been a member of this discussion board for ...more  
Comment by Lesalpes29 on Sep 01, 2022 5:58am
Last post on the Vera departure. Many good reasons could explain why she is leaving without a big thank you in a NR. I'm not seeing it negatively. She has done her job and we are on track for BTD or a JV with deep pockets or other positive developments. GL
Comment by stocksnbonds458 on Aug 31, 2022 5:43pm
The release Monday states that she has left the company.. I am sick about it, I assume she was not impressed with our future.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250